Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lensar (LNSR) Cash & Equivalents (2019 - 2026)

Lensar has reported Cash & Equivalents over the past 7 years, most recently at $12.9 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 20.96% to $12.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.9 million through Dec 2025, down 20.96% year-over-year, with the annual reading at $12.9 million for FY2025, 20.96% down from the prior year.
  • Cash & Equivalents was $12.9 million for Q4 2025 at Lensar, up from $7.6 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $35.9 million in Q1 2021 and troughed at $7.6 million in Q3 2025.
  • The 5-year median for Cash & Equivalents is $18.4 million (2023), against an average of $21.0 million.
  • Year-over-year, Cash & Equivalents plummeted 58.1% in 2024 and then grew 20.67% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $31.6 million in 2021, then decreased by 8.39% to $29.0 million in 2022, then decreased by 28.85% to $20.6 million in 2023, then decreased by 21.13% to $16.3 million in 2024, then dropped by 20.96% to $12.9 million in 2025.
  • Per Business Quant, the three most recent readings for LNSR's Cash & Equivalents are $12.9 million (Q4 2025), $7.6 million (Q3 2025), and $15.1 million (Q2 2025).